Non-small cell lung cancer Trials in Pittsburgh, United States
Conditions / Non-small cell lung cancer / Pittsburgh, United States
Non-small cell lung cancer has been the subject of sustained clinical investigation across multiple research sites.
134 total trials for this combination
Showing top 10 of 134 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03454451 | CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers | COMPLETED | PHASE1 |
| NCT06774963 | A Phase 1 Study of LNCB74 in Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT00858364 | Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy | TERMINATED | PHASE3 |
| NCT04234113 | Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors | TERMINATED | PHASE1 |
| NCT04585750 | The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) | RECRUITING | PHASE1/PHASE2 |
| NCT05576077 | A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors | TERMINATED | PHASE1 |
| NCT05563272 | 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors | TERMINATED | PHASE2 |
| NCT05259696 | Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) | COMPLETED | PHASE1/PHASE2 |
| NCT05877599 | A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation | RECRUITING | — |
| NCT03170960 | Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |